Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.
428% more first-time investments, than exits
New positions opened: 153 | Existing positions closed: 29
40% more funds holding in top 10
Funds holding in top 10: 15 → 21 (+6)
40% more capital invested
Capital invested by funds: $11.5B → $16B (+$4.55B)
30% more funds holding
Funds holding: 405 → 527 (+122)
8% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 171
21% less call options, than puts
Call options by funds: $167M | Put options by funds: $212M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$297M |
| 2 |
Two Sigma Advisers
New York
|
+$210M |
| 3 |
State Street
Boston,
Massachusetts
|
+$158M |
| 4 |
Renaissance Technologies
New York
|
+$146M |
| 5 |
Two Sigma Investments
New York
|
+$138M |
Top Sellers
ABMD Hedge Fund Activity: Q2 2018 in Review
527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.
Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.
The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.
- 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
- Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
- 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
- The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
- The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.
Based on aggregated 13F filings for Q2 2018.